Research In Brief
This article was originally published in The Tan Sheet
Executive Summary
Acetaminophen mechanism of action: Analgesic may work by inhibiting COX-3 activity in brain and spinal cord, N. V. Chandrasekharan, et al., Brigham Young University, report in online Proceedings of the National Academy of Sciences posted Sept. 19. BYU researchers say they found a third distinct COX enzyme, which they named COX-3, derived from same gene as COX-1. Researchers tested common analgesic/antipyretic drugs and NSAIDS for their ability to inhibit COX -1, -2 and -3 activity in presence of exogenously added arachidonic acid at two concentrations. "At the higher concentration of substrate, only COX-3 was inhibited by acetaminophen. Moreover, COX-3 was significantly more sensitive to acetaminophen than either COX-1 or- 2 at the lower substrate concentration," Chandrasekharan et al. report. Researchers say their findings suggest that "highly selective inhibitors can be made for COX-3"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning